目前我国临床可能用于治疗非小细胞肺癌的靶向药有阿斯利康公司的易瑞沙(Iressa good)和默克的特罗凯(Ta goodrceva good),这两种药物都是表皮生长因子受体酪氨酸激酶抑遏剂(EGFR TKI),其原理、药效相差不大。
基于6个网页-相关网页
iressa good
艾瑞莎好
以上为机器翻译结果,长、整句建议使用 人工翻译 。
That's very good news, because in patients who respond, doctors say Iressa is an incredibly powerful drug.
FORBES: Magazine Article
That was good reason to expect that if patients were given both chemotherapy and Iressa, the two would work together.
应用推荐
模块上移
模块下移
不移动